Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Casey Johnson

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Plos One|January 5, 2011
Immunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellinH Keipp Talbot, Michael T Rock, Casey Johnson, et al.
Vaccine|June 1, 2011
Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adultsChristine B Turley, Richard E Rupp, Casey Johnson, et al.
Open Forum Infectious Diseases|March 1, 2016
Phase 1 Safety and Immunogenicity Study of a Quadrivalent Seasonal Flu Vaccine Comprising Recombinant Hemagglutinin-Flagellin Fusion ProteinsLynda Tussey, Cynthia Strout, Matthew Davis, et al.
Human Vaccines|October 14, 2006
Exercise-induced serum enzyme elevations confounding the evaluation of investigational drug toxicity. Report of two cases in a vaccine trialCasey Johnson, Thomas P Monath, Niranjan Kanesa-Thasan, et al.
Plos One|August 31, 2018
Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosisNaim Alkhouri, Casey Johnson, Leon Adams, et al.
Plos One|October 5, 2018
Correction: Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosisNaim Alkhouri, Casey Johnson, Leon Adams, et al.
The Journal of Infectious Diseases|April 29, 2010
Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adultsJoanne M Langley, Louise Frenette, Linda Ferguson, et al.
Vaccine|April 20, 2005
A novel, cell culture-derived smallpox vaccine in vaccinia-naive adultsAndrew W Artenstein, Casey Johnson, Thomas C Marbury, et al.
The Journal of Infectious Diseases|October 11, 2003
Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigenThomas P Monath, Farshad Guirakhoo, Richard Nichols, et al.
Poultry Science|June 20, 2025
Recovery of Salmonella from alternative anatomical sites after an oral challenge with three different Salmonella serotypes in turkeysJ Allen Byrd, Sarah Faust, Denise Y Caldwell, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Plos One|January 5, 2011
Immunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellinH Keipp Talbot, Michael T Rock, Casey Johnson, et al.
Vaccine|June 1, 2011
Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adultsChristine B Turley, Richard E Rupp, Casey Johnson, et al.
Open Forum Infectious Diseases|March 1, 2016
Phase 1 Safety and Immunogenicity Study of a Quadrivalent Seasonal Flu Vaccine Comprising Recombinant Hemagglutinin-Flagellin Fusion ProteinsLynda Tussey, Cynthia Strout, Matthew Davis, et al.
Human Vaccines|October 14, 2006
Exercise-induced serum enzyme elevations confounding the evaluation of investigational drug toxicity. Report of two cases in a vaccine trialCasey Johnson, Thomas P Monath, Niranjan Kanesa-Thasan, et al.
Plos One|August 31, 2018
Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosisNaim Alkhouri, Casey Johnson, Leon Adams, et al.
Plos One|October 5, 2018
Correction: Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosisNaim Alkhouri, Casey Johnson, Leon Adams, et al.
The Journal of Infectious Diseases|April 29, 2010
Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adultsJoanne M Langley, Louise Frenette, Linda Ferguson, et al.
Vaccine|April 20, 2005
A novel, cell culture-derived smallpox vaccine in vaccinia-naive adultsAndrew W Artenstein, Casey Johnson, Thomas C Marbury, et al.
The Journal of Infectious Diseases|October 11, 2003
Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigenThomas P Monath, Farshad Guirakhoo, Richard Nichols, et al.
Poultry Science|June 20, 2025
Recovery of Salmonella from alternative anatomical sites after an oral challenge with three different Salmonella serotypes in turkeysJ Allen Byrd, Sarah Faust, Denise Y Caldwell, et al.
Pageof 5